Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -3.04% | -51.87% | -48.24% | -415.69% | -463.34% |
| Total Depreciation and Amortization | -11.63% | -6.06% | 2.93% | 8.71% | 13.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.91% | 39.58% | 44.09% | 582.86% | 1,401.72% |
| Change in Net Operating Assets | 6.47% | 717.65% | -73.95% | 255.02% | 237.49% |
| Cash from Operations | -6.34% | 51.74% | -401.25% | -2,550.60% | -84.02% |
| Capital Expenditure | -61.06% | -9.31% | 5.28% | 9.12% | 23.75% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -93.15% | -93.15% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.33% | -58.33% | -33.33% | -8.33% | 0.00% |
| Cash from Investing | -135.83% | -114.38% | -61.35% | -30.93% | -11.60% |
| Total Debt Issued | 13.26% | 13.26% | 266.54% | 1,439.17% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.26% | 13.26% | 272.85% | 1,153.77% | 981.17% |
| Foreign Exchange rate Adjustments | -39.72% | -247.50% | -177.23% | -260.49% | -187.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -338.35% | -769.49% | -236.48% | -234.12% | 1,443.48% |
